Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease.
Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Wallentin L 2nd. Diderholm E, et al. Among authors: lagerqvist b. Eur Heart J. 2002 Jan;23(1):41-9. doi: 10.1053/euhj.2001.2694. Eur Heart J. 2002. PMID: 11741361 Clinical Trial.
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy.
Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Venge P, Wallentin L; Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Diderholm E, et al. Among authors: lagerqvist b. Am Heart J. 2002 May;143(5):760-7. doi: 10.1067/mhj.2002.121733. Am Heart J. 2002. PMID: 12040335 Clinical Trial.
5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.
Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E, Wallentin L; Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators. Lagerqvist B, et al. Lancet. 2006 Sep 16;368(9540):998-1004. doi: 10.1016/S0140-6736(06)69416-6. Lancet. 2006. PMID: 16980115 Clinical Trial.
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Stenestrand U, James SK, Lindbäck J, Fröbert O, Carlsson J, Scherstén F, Nilsson T, Lagerqvist B; SCAAR/SWEDEHEART study group. Stenestrand U, et al. Among authors: lagerqvist b. Eur Heart J. 2010 Jan;31(2):177-86. doi: 10.1093/eurheartj/ehp424. Epub 2009 Nov 10. Eur Heart J. 2010. PMID: 19903684
Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
Eggers KM, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F, Peter T, Allhoff T, Siegbahn A, Venge P, Wollert KC, Wallentin L. Eggers KM, et al. Among authors: lagerqvist b. Circ Cardiovasc Genet. 2010 Feb;3(1):88-96. doi: 10.1161/CIRCGENETICS.109.877456. Epub 2009 Dec 11. Circ Cardiovasc Genet. 2010. PMID: 20160200
180 results